UK invests $13M+ in 17 biopharma manufacturers

The UK is mak­ing a £13 mil­lion in­vest­ment in­to 17 man­u­fac­tur­ers dot­ted through­out the coun­try.

The com­pa­nies do a range of work, in­clud­ing man­u­fac­tur­ing nu­cle­ic acid-based med­i­cines, au­tomat­ing or dig­i­tal­iz­ing man­u­fac­tur­ing ef­forts, or de­vel­op­ing meth­ods around in­tra­cel­lu­lar drug de­liv­ery for vac­cines. The funds come from In­no­vate UK, a pub­lic en­ti­ty sup­port­ing tech­nol­o­gy and sci­ence busi­ness­es.

This in­cludes con­tract man­u­fac­tur­er Rentschler Bio­phar­ma, which plans to im­ple­ment an­a­lyt­i­cal tech­nolo­gies to boost ef­fi­cien­cy in the pro­duc­tion of gene ther­a­pies. Rentschler re­cent­ly built a cell and gene man­u­fac­tur­ing site in Steve­nage.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.